Portola Pharmaceuticals, Inc. Announces Upcoming Data Presentations On Andexanet Alfa (PRT4445*) And PRT2070 At 55th American Society of Hematology Annual Meeting

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SOUTH SAN FRANCISCO, Calif., Dec. 3, 2013 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. (Nasdaq:PTLA) today announced two upcoming data presentations at the 55th American Society of Hematology (ASH) Annual Meeting and Exposition, which is being held in New Orleans from December 7-10. The Company also will webcast an investor briefing during the ASH Annual Meeting.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC